tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andy Hsieh, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Andy Hsieh, currently employed at WILLIAM BLAIR, carries an average stock price target met ratio of 100% that have a potential upside of 13.74% achieved within 57 days.
Andy Hsieh’s has documented 5 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FGEN, FibroGen at 26-Jun-2023.
Analyst best performing recommendations are on FGEN (FIBROGEN).
The best stock recommendation documented was for FGEN (FIBROGEN) at 8/8/2017. The price target of $1407.5 was fulfilled within 57 days with a profit of $170 (13.74%) receiving and performance score of 2.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$10
$1.2 (13.64%)
$10
1 years 4 months 19 days ago
(13-May-2025)
3/3 (100%)
$2.52 (33.69%)
87
Hold Since 08-Aug-2023
$50
$40.78 (442.30%)
3 years 1 months 24 days ago
(08-Aug-2023)
1/4 (25%)
$14 (38.89%)
177
Buy Since 27-Jun-2023
$875
3 years 3 months 5 days ago
(27-Jun-2023)
2/4 (50%)
$322.25 (58.30%)
15
Buy Since 26-Jun-2023
$800
3 years 3 months 6 days ago
(26-Jun-2023)
1/5 (20%)
$353 (78.97%)
389
Hold Since 01-May-2020
$75
$65.78 (713.45%)
3 years 3 months 6 days ago
(26-Jun-2023)
1/2 (50%)
$7.25 (10.70%)
47
What Year was the first public recommendation made by Andy Hsieh?
